Helen Dakin

Summary

Publications

  1. ncbi Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective
    Helen Dakin
    Abacus International, Bicester, UK
    Pharmacoeconomics 29:1075-91. 2011
  2. ncbi "Yes", "No" or "Yes, but"? Multinomial modelling of NICE decision-making
    Helen Angela Dakin
    Abacus International, 3 4 Market Square, Bicester, Oxon OX26 6AA, UK
    Health Policy 77:352-67. 2006
  3. ncbi Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom
    Helen Dakin
    Abacus International, Bicester, Oxfordshire, United Kingdom
    Clin Ther 29:1491-507. 2007
  4. ncbi Cost-utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B
    Helen Dakin
    Abacus International, Bicester, Oxfordshire, UK
    Value Health 13:922-33. 2010
  5. ncbi Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B
    Helen Dakin
    Abacus International, Bicester, Oxfordshire, UK
    Value Health 13:934-45. 2010

Detail Information

Publications5

  1. ncbi Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective
    Helen Dakin
    Abacus International, Bicester, UK
    Pharmacoeconomics 29:1075-91. 2011
    ..However, to our knowledge, no published studies have yet evaluated the cost effectiveness of any treatments for CHB in a Canadian setting, where relative prices and management of CHB differ from those in Europe...
  2. ncbi "Yes", "No" or "Yes, but"? Multinomial modelling of NICE decision-making
    Helen Angela Dakin
    Abacus International, 3 4 Market Square, Bicester, Oxon OX26 6AA, UK
    Health Policy 77:352-67. 2006
    ....
  3. ncbi Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom
    Helen Dakin
    Abacus International, Bicester, Oxfordshire, United Kingdom
    Clin Ther 29:1491-507. 2007
    ..A lidocaine 5% medicated plaster marketed in the United Kingdom in January 2007 has been shown to be an effective topical treatment for PHN with minimal risk of systemic adverse effects...
  4. ncbi Cost-utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B
    Helen Dakin
    Abacus International, Bicester, Oxfordshire, UK
    Value Health 13:922-33. 2010
    ..The aim of this study was to assess the cost-effectiveness of tenofovir disoproxil fumarate (TDF) in the treatment of chronic hepatitis B (CHB) versus alternative nucleos(t)ides from a UK National Health Service (NHS) perspective...
  5. ncbi Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B
    Helen Dakin
    Abacus International, Bicester, Oxfordshire, UK
    Value Health 13:934-45. 2010
    ..This meta-analysis aimed to assess the relative efficacy of adefovir, entecavir, lamivudine, telbivudine, tenofovir disoproxil fumarate (TDF), and nucleos(t)ide combinations in the treatment of CHB...